Sumitomo Financial Statements From 2010 to 2024
| DPM Stock | EUR 2.28 0.06 2.56% |
Check Sumitomo Dainippon financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sumitomo main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Sumitomo financial statements analysis is a perfect complement when working with Sumitomo Dainippon Valuation or Volatility modules.
Sumitomo |
Sumitomo Dainippon Pharma Company Operating Margin Analysis
Sumitomo Dainippon's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Sumitomo Dainippon Operating Margin | (0.03) % |
Most of Sumitomo Dainippon's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sumitomo Dainippon Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Sumitomo Dainippon Pharma has an Operating Margin of -0.0273%. This is 99.92% lower than that of the Healthcare sector and 99.93% lower than that of the Drug Manufacturers - Specialty & Generic industry. The operating margin for all Germany stocks is 99.5% lower than that of the firm.
Sumitomo Dainippon Pharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sumitomo Dainippon's current stock value. Our valuation model uses many indicators to compare Sumitomo Dainippon value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sumitomo Dainippon competition to find correlations between indicators driving Sumitomo Dainippon's intrinsic value. More Info.Sumitomo Dainippon Pharma is one of the top stocks in return on equity category among related companies. It is one of the top stocks in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sumitomo Dainippon by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sumitomo Dainippon's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sumitomo Dainippon's earnings, one of the primary drivers of an investment's value.About Sumitomo Dainippon Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Sumitomo Dainippon income statement, its balance sheet, and the statement of cash flows. Sumitomo Dainippon investors use historical funamental indicators, such as Sumitomo Dainippon's revenue or net income, to determine how well the company is positioned to perform in the future. Although Sumitomo Dainippon investors may use each financial statement separately, they are all related. The changes in Sumitomo Dainippon's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Sumitomo Dainippon's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Sumitomo Dainippon Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Sumitomo Dainippon. Please read more on our technical analysis and fundamental analysis pages.
Sumitomo Dainippon Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients and additives, veterinary medicines, diagnostics, and others. Sumitomo Dainippon Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited. SUMITOMO DAINIPPON operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 6140 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sumitomo Dainippon in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sumitomo Dainippon's short interest history, or implied volatility extrapolated from Sumitomo Dainippon options trading.
Pair Trading with Sumitomo Dainippon
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sumitomo Dainippon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sumitomo Dainippon will appreciate offsetting losses from the drop in the long position's value.Moving together with Sumitomo Stock
| 0.62 | EII | Eisai Co | PairCorr |
Moving against Sumitomo Stock
| 0.87 | 0C8 | Catalent | PairCorr |
| 0.8 | RDDA | Dr Reddys Laboratories | PairCorr |
| 0.68 | E908 | Lyxor 1 | PairCorr |
| 0.55 | TEV | Teva Pharmaceutical | PairCorr |
| 0.52 | BUU | DevEx Resources | PairCorr |
The ability to find closely correlated positions to Sumitomo Dainippon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sumitomo Dainippon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sumitomo Dainippon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sumitomo Dainippon Pharma to buy it.
The correlation of Sumitomo Dainippon is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sumitomo Dainippon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sumitomo Dainippon Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sumitomo Dainippon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Sumitomo Dainippon Correlation against competitors. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Sumitomo Stock analysis
When running Sumitomo Dainippon's price analysis, check to measure Sumitomo Dainippon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sumitomo Dainippon is operating at the current time. Most of Sumitomo Dainippon's value examination focuses on studying past and present price action to predict the probability of Sumitomo Dainippon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sumitomo Dainippon's price. Additionally, you may evaluate how the addition of Sumitomo Dainippon to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |